Crotamiton
As of the edition of 20 October 2026, Crotamiton is a drug: marketed, first approved in 1953 (CA).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1996
- Kind
- Unknown
- Brand name
- Eurax
- First approved
- 31 December 1953 (CA)
- Approvals on record
- 4 in 3 regions
- Holder of the most recent approval
- EG LABO - LABORATOIRES EUROGENERICS; 3 holders in all
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Coronado Biosciences | Acquired holder | 2021 to now |
| Westwood Squibb Pharmaceuticals | Earlier holder |